12 Weeks of Resistance Band Exercise Impacts on Metabolic Syndrome Progression in Postmenopausal Women

Impacts of 12 Weeks of Resistance Band Exercise Training on Insulin Resistance, Blood Lipids, Body Composition, and Blood Pressure in Postmenopausal Women With Obesity

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04014686

Enrollment

Registered

2019-07-10

Start date

2018-04-01

Completion date

2018-10-01

Last updated

2020-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyslipidemias, Hypertension, Insulin Resistance, Metabolic Syndrome

Keywords

postmenopausal, exercise

Brief summary

The purpose of this study was to examine the impacts of a 12-week resistance band exercise program on insulin resistance, blood lipid profiles, body composition, and blood pressure in postmenopausal women with obesity. Thirty-six postmenopausal women participated in this study. Participants were randomly allocated into the resistance band training group (EX, n = 18) or the control group (CON, n = 18). The EX group performed a resistance band exercise training program 60 minutes per day, 3 times per week, for 12 weeks. The CON group did not participate in any exercise, dietary, or behavioral intervention. Blood glucose, insulin, homeostatic model of insulin resistance (HOMA-IR), blood lipids, blood pressure, and body composition were measured before and after 12 weeks of EX or CON.

Interventions

OTHERNo exercise intervention group

no exercise intervention

BEHAVIORALResistance band exercise intervention group

Resistance band exercise training intervention (12 weeks, 3x per week, for 60 minutes per day)

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Intervention model description

exercise intervention group, control group

Eligibility

Sex/Gender

FEMALE

Healthy volunteers

Inclusion criteria

* postmenopausal (cessation of menses for at least 12 consecutive months) * abdominal obesity (waist \> 80 cm)

Exclusion criteria

* current smoker (smoking within 6 months of participation) * cardiovascular disease * renal disease * pulmonary disease * thyroid disease

Design outcomes

Primary

Measure	Time frame	Description
Glucose	12 weeks	Blood glucose was measured before and after 12 weeks.
Insulin	12 weeks	Blood insulin was measured before and after 12 weeks.
Percentage of Body Fat	12 weeks	Body fat percentage was measured before and after 12 weeks.
Waist circumference	12 weeks	Waist circumference was measured before and after 12 weeks.

Secondary

Measure	Time frame	Description
Systolic blood pressure	12 weeks	Systolic blood pressure was measured before and after 12 weeks.
Diastolic blood pressure	12 weeks	Diastolic blood pressure was measured before and after 12 weeks.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026